BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25861033)

  • 1. Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men.
    Hu MB; Bai PD; Wu YS; Zhang LM; Xu H; Na R; Jiang HW; Ding Q
    PLoS One; 2015; 10(4):e0124668. PubMed ID: 25861033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study.
    Baio R; Napodano G; Caruana C; Molisso G; Di Mauro U; Intilla O; Pane U; D'Angelo C; Francavilla AB; Guarnaccia C; Pentimalli F; Sanseverino R
    Mol Clin Oncol; 2022 Aug; 17(2):127. PubMed ID: 35832470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waist-hip Ratio (WHR), a Better Predictor for Prostate Cancer than Body Mass Index (BMI): Results from a Chinese Hospital-based Biopsy Cohort.
    Tang B; Han CT; Zhang GM; Zhang CZ; Yang WY; Shen Y; Vidal AC; Freedland SJ; Zhu Y; Ye DW
    Sci Rep; 2017 Mar; 7():43551. PubMed ID: 28272469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy?
    Chamie K; Oberfoell S; Kwan L; Labo J; Wei JT; Litwin MS
    Urology; 2013 May; 81(5):949-55. PubMed ID: 23477756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis.
    De Nunzio C; Freedland SJ; Miano L; Finazzi Agrò E; Bañez L; Tubaro A
    Eur J Surg Oncol; 2011 Dec; 37(12):1025-9. PubMed ID: 21963050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agent Orange as a risk factor for high-grade prostate cancer.
    Ansbaugh N; Shannon J; Mori M; Farris PE; Garzotto M
    Cancer; 2013 Jul; 119(13):2399-404. PubMed ID: 23670242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy.
    Oh JJ; Jeong SJ; Lee BK; Jeong CW; Byun SS; Hong SK; Lee SE
    BJU Int; 2013 Aug; 112(4):E265-71. PubMed ID: 23432960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese Population.
    Fang D; Zhao C; Ren D; Yu W; Wang R; Wang H; Li X; Yin W; Yu X; Yang K; Liu P; Shan G; Li S; He Q; Wang X; Xin Z; Zhou L
    Ann Surg Oncol; 2016 Dec; 23(13):4284-4292. PubMed ID: 27464612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4-10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score.
    Fang D; Ren D; Zhao C; Li X; Yu W; Wang R; Wang H; Xi C; He Q; Wang X; Xin Z; Zhou L
    Biomed Res Int; 2015; 2015():596797. PubMed ID: 26557679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI trajectories and risk of overall and grade-specific prostate cancer: An observational cohort study among men seen for prostatic conditions.
    Wang K; Chen X; Gerke TA; Bird VY; Ghayee HK; Prosperi M
    Cancer Med; 2018 Oct; 7(10):5272-5280. PubMed ID: 30207080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea.
    Park J; Cho SY; Lee SB; Son H; Jeong H
    BJU Int; 2014 Dec; 114(6):891-5. PubMed ID: 24314095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy.
    Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS
    Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.
    Liang Y; Ketchum NS; Louden C; Jimenez-Rios MA; Thompson IM; Camarena-Reynoso HR
    Urol Int; 2012; 89(1):9-16. PubMed ID: 22626812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer detection: The impact of obesity on Asian men.
    Lee A; Chia SJ
    Urol Oncol; 2015 Jun; 33(6):266.e17-22. PubMed ID: 25865574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis.
    Bai PD; Hu MB; Xu H; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
    World J Surg Oncol; 2015 Nov; 13():311. PubMed ID: 26542246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index influences prostate cancer risk at biopsy in Japanese men.
    Masuda H; Kagawa M; Kawakami S; Numao N; Matsuoka Y; Yokoyama M; Yamamoto S; Yonese J; Fukui I; Kihara K
    Int J Urol; 2013 Jul; 20(7):701-7. PubMed ID: 23186107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of prostate imaging reporting and data system version 2 (PI-RADS v2) and periprostatic fat thickness on multi-parametric MRI to predict the presence of prostate cancer.
    Cao Y; Cao M; Chen Y; Yu W; Fan Y; Liu Q; Gao G; Zhao Z; Wang X; Jin J
    Oncotarget; 2017 Jul; 8(27):44040-44049. PubMed ID: 28476042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.
    Niu XK; Li J; Das SK; Xiong Y; Yang CB; Peng T
    BMC Med Imaging; 2017 Feb; 17(1):11. PubMed ID: 28143433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.